Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Ranxin Zhang"'
Autor:
Jichuan Wang, Zhiqing Zhao, Haijie Liang, Ranxin Zhang, Xingyu Liu, Jing Zhang, Swapnil Singh, Wei Guo, Taiqiang Yan, Bang H. Hoang, David S. Geller, Xiaodong Tang, Rui Yang
Publikováno v:
Frontiers in Bioengineering and Biotechnology, Vol 12 (2024)
BackgroundThe percutaneous screw reconstruction technique, known as the “Tripod Technique,” has demonstrated favorable clinical outcomes in the management of metastatic periacetabular lesions, as evidenced by our prior investigations and corrobor
Externí odkaz:
https://doaj.org/article/6b9bae22478e487e9fc04c555dfee5aa
Publikováno v:
Asian Pacific Journal of Tropical Medicine, Vol 15, Iss 6, Pp 266-273 (2022)
Externí odkaz:
https://doaj.org/article/8d48f2a500944454be6ad8ceca3b36a7
Autor:
Jun Wang, Hongliang Zhang, Xin Sun, Xiaofang Wang, Tingting Ren, Yi Huang, Ranxin Zhang, Bingxin Zheng, Wei Guo
Publikováno v:
Journal of Nanobiotechnology, Vol 18, Iss 1, Pp 1-23 (2020)
Abstract Background Recent studies indicated that exosomal programmed death-ligand 1 (PD-L1) derived from cancers could induce immunosuppression and tumor pathogenesis. However, it is unclear how exosomes influence osteosarcoma (OS) progression and w
Externí odkaz:
https://doaj.org/article/22156c2ee5d84f5f9378fb6cb89f56e2
Autor:
Zhenyu Cai, Jie Xu, Xin Sun, Ranxin Zhang, Lu Xie, Jichuan Wang, Xiaodong Tang, Rongli Yang, Wei Guo
Publikováno v:
International Orthopaedics. 46:2425-2436
Pulmonary metastasis was a negative factor of osteosarcoma prognosis. However, there is no universal criteria to confirm pulmonary metastasis at pulmonary micro nodule (PMN, Dmax ≤ 5 mm) stage other than pathology. We aimed to identify prevalence o
Autor:
Jichuan Wang, Alexander Ferrena, Swapnil Singh, Ranxin Zhang, Valentina Viscarret, Waleed Al-Hardan, Osama Aldahamsheh, Hasibagan Borjihan, Amit Singla, Simon Yaguare, Janet Tingling, Xiaolin Zi, Yungtai Lo, Richard Gorlick, Edward L. Schwartz, Hongling Zhao, Rui Yang, David S. Geller, Deyou Zheng, Bang H. Hoang
Osteosarcoma(OS) is a highly aggressive bone cancer for which treatment has remained essentially unchanged for decades. Although OS is characterized by extensive genomic heterogeneity and instability,RB1andTP53have been shown to be the most commonly
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7e9d2b5314192ceeea47b17b38ef0c21
https://doi.org/10.1101/2023.05.13.540637
https://doi.org/10.1101/2023.05.13.540637
Autor:
Alexander Ferrena, Jichuan Wang, Ranxin Zhang, Burcu Karadal-Ferrena, Waleed Al-Hardan, Swapnil Singh, Hasibagan Borjihan, Edward Schwartz, Hongling Zhao, Rui Yang, David Geller, Bang Hoang, Deyou Zheng
PurposeOsteosarcoma (OS) is an aggressive bone malignancy with a poor prognosis. One putative proto-oncogene in OS isSKP2, encoding a substrate recognition factor of the SCF E3 ubiquitin ligase. We previously demonstrated thatSKP2knockout in murine O
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d2597e32a779dc2d0395cdd9778badb0
https://doi.org/10.1101/2023.05.09.540053
https://doi.org/10.1101/2023.05.09.540053
Autor:
Alexander Ferrena, Jichuan Wang, Ranxin Zhang, Rui Yang, David Geller, Bang Hoang, Deyou Zheng
Publikováno v:
Cancer Research. 83:553-553
Background: Osteosarcoma (OS) is an aggressive cancer of the bone with a poor prognosis. OS often involve mutations of tumor suppressors RB1 and TP53. One putative proto-oncogene in OS is SKP2, which codes for a substrate-recognition factor of the SC
Autor:
Jichuan Wang, Alexander Ferrena, Ranxin Zhang, Swapnil Singh, Hongling Zhao, Deyou Zheng, Hasibagan Borjihan, Waleed Al-Harden, Janet Tingling, Rui Yang, David S. Geller, Bang H. Hoang
Publikováno v:
Cancer Research. 82:6188-6188
Background: Osteosarcoma (OS) is a highly aggressive bone malignancy for which treatment has remained unchanged for years. Our previous studies indicate that the F-box protein SKP2 is overexpressed in OS and acts as a proto-oncogene. We recently repo
Autor:
Xin Sun, Hongliang Zhang, Tingting Ren, Jun Wang, Yi Huang, Bingxin Zheng, Wei Guo, Xiaofang Wang, Ranxin Zhang
Publikováno v:
Journal of Nanobiotechnology
Journal of Nanobiotechnology, Vol 18, Iss 1, Pp 1-23 (2020)
Journal of Nanobiotechnology, Vol 18, Iss 1, Pp 1-23 (2020)
Background Recent studies indicated that exosomal programmed death-ligand 1 (PD-L1) derived from cancers could induce immunosuppression and tumor pathogenesis. However, it is unclear how exosomes influence osteosarcoma (OS) progression and whether PD
Autor:
Bingxin Zheng, Tingting Ren, Jun Wang, Hongliang Zhang, Yi Huang, Wei Guo, Xin Sun, Ranxin Zhang, Xiaofang Wang
Background Recent studies indicated that exosomal programmed death-ligand 1 (PD-L1) derived from cancers could induce immunosuppression and tumor pathogenesis. However, it is unclear how the exosome influences the osteosarcoma (OS) progression and wh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::60492ff67c7639554a132426595ac837
https://doi.org/10.21203/rs.3.rs-40872/v1
https://doi.org/10.21203/rs.3.rs-40872/v1